M&A: To Deal or Not to Deal

In a capital constrained environment, some might argue that now is not the time for businesses to be pursuing growth via M&A. Others might posit that the best deals are struck at weak points in the economic cycle. Senior Editor Jacob Ambrose Willson asks Criticaleye Members for their views on executing M&A in 2023 and beyond.

Featuring Commentary From:

Michel Driessen, Senior Partner, Strategy and Transactions, EY
Alastair Mills, Managing Director & Head of European Business Services, H.I.G. Capital
Michael Teixeira, CEO, MVF
Helen Wiseman, Chair, Elixinol Wellness




Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.

Click here to download this insight
The Empowered Consumer

In a world where companies are increasingly focusing on customer-centricity and personalised experiences, why are 74 percent of consumers walking away from purchases? In this report, Criticaleye Partner Accenture&n...

Click here to download this insight
Do Female Leaders View Disrup...

This report by Criticaleye Partner,  AlixPartners explores how female C-level and senior executives are navigating current disruptions by actively seeking new opportunities from the uncertainty ahead. Key Takewa...

Click here to download this insight
The Highs and Lows of an IPO

The IPO process is becoming more complex and issues within the UK’s capital markets remain front of mind for executives. Senior Editor Jacob Ambrose Willson asks Members of Criticaleye’s Growth Company Commu...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 1,521




Workday AlixPartners Experian E.ON UK Redwood Bank Tullow Oil plc London Stock Exchange Accenture Salesforce Lightsource bp Concentrix Veolia Water Technologies Amazon UK Legal & General Investment Management Royal London Group NATS Google LDC Robert Walters Drax Group plc Mayborn Group Bunzl plc Eton Bridge Partners Eightfold AI GlaxoSmithKline plc